M06.051, Rheumatoid arthritis without rheumatoid factor, right hipICD-10-CM
No Prior Auth Required
Covered without prior authorization by at least one policy, though another does not cover it (medium confidence)
CGS-J15-L34394, Visual Fields Testing
J15
CGS-J15-L40386, Erythropoiesis Stimulating Agents (ESA)
J15
CGS-J15-L34399, Ophthalmology: Posterior Segment Imaging (Extended Ophthalmoscopy and Fundus Photography)
J15
CGS-J15-L34175, Ophthalmic Angiography (Fluorescein and Indocyanine Green)
J15
CGS-J15-L40232, Total Joint Arthroplasty
J15
CGS-J15-L34356, Erythropoiesis Stimulating Agents (ESA)
J15
CGS-J15-L34246, Routine Foot Care and Debridement of Nails
J15
CGS-J15-L39427, MolDX: Molecular Biomarker Testing to Guide Targeted Therapy Selection in Rheumatoid Arthritis
J15
CGS-J18-L34175, Ophthalmic Angiography (Fluorescein and Indocyanine Green)
J18
CGS-J18-L40386, Erythropoiesis Stimulating Agents (ESA)
J18
CGS-J18-L40232, Total Joint Arthroplasty
J18
CGS-J18-L34399, Ophthalmology: Posterior Segment Imaging (Extended Ophthalmoscopy and Fundus Photography)
J18
CGS-J18-L34394, Visual Fields Testing
J18
CGS-J18-L34246, Routine Foot Care and Debridement of Nails
J18
CGS-J18-L34356, Erythropoiesis Stimulating Agents (ESA)
J18
CGS-J18-L39427, MolDX: Molecular Biomarker Testing to Guide Targeted Therapy Selection in Rheumatoid Arthritis
J18
WPS-J5-L39481, MolDX: Molecular Biomarker Testing to Guide Targeted Therapy Selection in Rheumatoid Arthritis
J5
WPS-J5-L34633, Erythropoiesis Stimulating Agents (ESAs)
J5
WPS-J5-L37205, Chemotherapy Drugs and their Adjuncts
J5
WPS-J5-L39911, Total Joint Arthroplasty
J5
Ask Backwork about documentation requirements, denial risks, or coverage in your state.